Recruiting

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(18 sites)

United States

University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama

University of California, San Diego School of Medicine, La Jolla, California

Stanford University, Redwood City, California

University of California, San Francisco, San Francisco, California

University of Miami, Jackson Memorial Hospital, Miami, Florida

Emory University Hospital, Atlanta, Georgia

Northwestern University, Feinberg School of Medicine, Chicago, Illinois

Johns Hopkins University School of Medicine, Baltimore, Maryland

University of Michigan Medical Center, Ann Arbor, Michigan

Mayo Clinic, Rochester - College of Medicine and Science, Rochester, Minnesota

University of Nebraska Medical Center, Omaha, Nebraska

Duke University School of Medicine, Durham, North Carolina

Oregon Health & Sciences University, Portland, Oregon

University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Vanderbilt University School of Medicine, Nashville, Tennessee

University of Texas Southwestern Medical Center, Dallas, Texas

University of Washington Medical Center: Transplantation, Seattle, Washington